SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 9, 2004 DIALYSIS CORPORATION OF AMERICA (Exact name of registrant as specified in its charter) Florida 0-8527 59-1757642 (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 1344 Ashton Road, Hanover, Maryland 21076 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (410) 694-0500 Item 4. Change in Registrant's Certifying Accountant The audit committee has retained Moore Stephens, P.C., as the company's new independent auditors and for tax preparation services for fiscal 2003. Moore Stephens will also be reviewing the company's quarterly reports for 2004. The engagement was formalized on January 9, 2004. Moore Stephens is replacing Wiss & Company, LLC, which accounting firm discontinued providing SEC audit services to its SEC clients, which included the company. Wiss & Company's termination was reported in the company's quarterly report dated November 7, 2003 on Form 10-Q for the third quarter ended September 30, 2003. There have been no consultations with Moore Stephens during the two most recent fiscal years prior to its engagement as the company's new independent auditors. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DIALYSIS CORPORATION OF AMERICA /s/ Stephen W. Everett By--------------------------------- STEPHEN W. EVERETT, Chief Executive Officer and President Dated: January 12, 2004